Cargando…
Increased bleeding and thrombosis in myeloproliferative neoplasms mediated through altered expression of inherited platelet disorder genes
An altered thrombo-hemorrhagic profile has long been observed in patients with myeloproliferative neoplasms (MPNs). We hypothesized that this observed clinical phenotype may result from altered expression of genes known to harbor genetic variants in bleeding, thrombotic, or platelet disorders. Here,...
Autores principales: | Mitchell, Alan, Frontini, Mattia, Islam, Serajul, Sivapalaratnam, Suthesh, Krishnan, Anandi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245891/ https://www.ncbi.nlm.nih.gov/pubmed/37292725 http://dx.doi.org/10.1101/2023.05.23.541977 |
Ejemplares similares
-
Platelet proteo-transcriptomic profiling validates mediators of thrombosis and proteostasis in patients with myeloproliferative neoplasms
por: Kelliher, Sarah, et al.
Publicado: (2023) -
Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms
por: Shen, Zhu, et al.
Publicado: (2021) -
Enkurin: A novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens
por: Mosale Seetharam, Sumanth, et al.
Publicado: (2023) -
Enkurin: a novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens
por: Seetharam, Sumanth Mosale, et al.
Publicado: (2023) -
Mechanisms of platelet activation in cancer-associated thrombosis: a focus on myeloproliferative neoplasms
por: Bekendam, Roelof H., et al.
Publicado: (2023)